Genmab — Maj 2020
-
Novartis' repurposed leukemia drug tops Sanofi's Aubagio in MS study weeks ahead of FDA verdict https://www.fiercepharma.com/pharma/novartis-repurposed-leukemia-drug-tops-sanofi-s-aubagio-ms-study-weeks-ahead-fda-verdict
-
ASCO: Stay alert. Fradag kl. 14 er der virtuelle præsentationer af Epcoritamab, Amivantamab, TV og Teclistamab
-
Tak Pensionist.
-
God morgen
-
Ocrevus ned fra 3½ til 2 timers infusionstid https://www.inderes.fi/en/tiedotteet/roches-ocrevus-ocrelizumab-shorter-2-hour-infusion-time-approved-europe
-
Robothandel i Genmab 17,30 min. inde i udsendelsen. https://www.proinvestor.com/debat/84426
-
Markant bedre dag i end i går
-
hold da op noget vrøvl. Markant bedre dag i dag, end i går.
-
Lego -
Ocrevus er konkurrent til ofa ikke dara -
Det betyder nok mere for sygehuset end for patienten. Det gode spm er om pts med lang transportvej vil foretrække månedlig hjemmeadministreret sc frem for ½-årligt besøg på sygehuset. For folk der bor i byerne inden for 1 time fra et infusionscenter, tja? Man får en tid, skal måske tage fri fra arbejde, det slipper man for med sc hjemme.
-
Women of childbearing age are advised to use adequate contraception while being treated with Ocrevus. https://multiplesclerosisnewstoday.com/2017/04/03/points-multiple-sclerosis-patients-should-know-about-ocrevus-its-use/
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind